In a departure from most deals, startup insitro will in-license Lilly’s delivery technology for its investigational ...

Managers face a variety of challenges during their careers. Instead of falling into fight or flight, develop resilience to ...

The FDA’s reviewers pointed out that Stealth’s elamipretide missed its primary efficacy endpoints in the main study used to ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

The rejection is related to the timing of the FDA’s reinspection of Zealand’s third-party manufacturer, which previously had ...